Benzinga's Top #PreMarket Gainers
March 20, 2014 at 08:08 AM EDT
Synta Pharmaceuticals (NASDAQ: SNTA) surged 30.53% to $6.20 in the pre-market session on positive interim results from the ENCHANT-1 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.